funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
United States
HQ address
45085 University Dr, Ashburn, 20147, USA
From a single test, Aperiomics' innovative technology can simultaneously test for all pathogens, whether bacteria, virus, fungus, or parasite. Since this unique system uses an unbiased sequencing and genomic analysis approach, it is perfect for pathogen discovery, diagnosing difficult cases of unknown etiology, pathogen surveillance, and monitoring of natural animal populations, as well as routine pathogen detection. With a novel combination of genomics and informatics, Aperiomics capitalizes on high-throughput next generation sequencing and advanced Bayesian statistics to produce more accurate results than other molecular-based approaches and faster, more accurate results than other culture-based methods. In more simple terms, Aperiomics has combined genetic sequencing with computational power to give a quick answer even if you don’t know what the question should be.

Absolute*ID - Identify known pathogens
Absolute*Discover - Discover new pathogens
Absolute*Biome - Characterize microbial populations

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats